161 related articles for article (PubMed ID: 12464232)
1. Overgrowth.
Ambler G
Best Pract Res Clin Endocrinol Metab; 2002 Sep; 16(3):519-46. PubMed ID: 12464232
[TBL] [Abstract][Full Text] [Related]
2. Genetic causes of proportionate short stature.
Argente J; Pérez-Jurado LA
Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):499-522. PubMed ID: 30086871
[TBL] [Abstract][Full Text] [Related]
3. Current concepts in tall stature and overgrowth syndromes.
Drop SL; Greggio N; Cappa M; Bernasconi S;
J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():975-84. PubMed ID: 11529404
[TBL] [Abstract][Full Text] [Related]
4. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.
Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Balivo F; Piccolo P; Di Somma C; Colao A; Andria G
J Pediatr; 2010 Apr; 156(4):663-70.e1. PubMed ID: 20022338
[TBL] [Abstract][Full Text] [Related]
5. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
6. [Growth Hormone-Insulin Growth Factor I (GH-IGF-I) axis and growth].
Castell AL; Sadoul JL; Bouvattier C
Ann Endocrinol (Paris); 2013 Oct; 74 Suppl 1():S33-41. PubMed ID: 24356290
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of growth disorders in the paediatric clinic.
Cappa M; Loche S
J Endocrinol Invest; 2003; 26(7 Suppl):54-63. PubMed ID: 14604067
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?
Savage MO; Camacho-Hübner C; David A; Metherell LA; Hwa V; Rosenfeld RG; Clark AJ
Eur J Endocrinol; 2007 Aug; 157 Suppl 1():S33-7. PubMed ID: 17785695
[TBL] [Abstract][Full Text] [Related]
9. The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges.
Savage MO; Burren CP; Rosenfeld RG
Clin Endocrinol (Oxf); 2010 Jun; 72(6):721-8. PubMed ID: 20050859
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic short stature.
Pasquino AM; Albanese A; Bozzola M; Butler GE; Buzi F; Cherubini V; Chiarelli F; Cavallo L; Drop SL; Stanhope R; Kelnar CJ;
J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():967-74. PubMed ID: 11529403
[TBL] [Abstract][Full Text] [Related]
11. Introduction to the study of pre- and postnatal growth in humans: a review.
Mendez H
Am J Med Genet; 1985 Jan; 20(1):63-85. PubMed ID: 3881956
[TBL] [Abstract][Full Text] [Related]
12. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001.
Lee PA; Chernausek SD; Hokken-Koelega AC; Czernichow P;
Pediatrics; 2003 Jun; 111(6 Pt 1):1253-61. PubMed ID: 12777538
[TBL] [Abstract][Full Text] [Related]
13. MANAGEMENT OF ENDOCRINE DISEASE: Diagnostic and therapeutic approach of tall stature.
Albuquerque EVA; Scalco RC; Jorge AAL
Eur J Endocrinol; 2017 Jun; 176(6):R339-R353. PubMed ID: 28274950
[TBL] [Abstract][Full Text] [Related]
14. Short stature in genetic syndromes: Selected issues.
Łaczmańska I; Kuliczkowska-Płaksej J; Stembalska A
Adv Clin Exp Med; 2018 Mar; 27(3):409-414. PubMed ID: 29558022
[TBL] [Abstract][Full Text] [Related]
15. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
16. Final height in patients with idiopathic short stature and high growth hormone responses to stimulation tests.
Martinelli CE; Sader Milani S; Previato JK; Figueira M; Rangel Montenegro AP; Miraki-Moud F; Betancourth S; Moreira AC; Savage MO; Camacho-Hübner C
Horm Res; 2007; 67(5):224-30. PubMed ID: 17135759
[TBL] [Abstract][Full Text] [Related]
17. Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome.
Burren CP; Woods KA; Rose SJ; Tauber M; Price DA; Heinrich U; Gilli G; Razzaghy-Azar M; Al-Ashwal A; Crock PA; Rochiccioli P; Yordam N; Ranke MB; Chatelain PG; Preece MA; Rosenfeld RG; Savage MO
Horm Res; 2001; 55(3):125-30. PubMed ID: 11549873
[TBL] [Abstract][Full Text] [Related]
18. Growth and management of short stature in thalassaemia major.
Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology, assessment and management of the child with growth hormone resistance.
Savage MO; Cohen L; Cohen AJ; Cohen P; Saenger PH
Pediatr Endocrinol Rev; 2010 Jun; 7(4):347-56. PubMed ID: 20679995
[TBL] [Abstract][Full Text] [Related]
20. Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birthweight.
Yang SW; Yu JS
Pediatr Int; 2000 Feb; 42(1):31-6. PubMed ID: 10703231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
